Hydrofarm Holdings Group earnings release, May 15, 2026

Hydrofarm Holdings Group, Inc. (HYFM) · Form 8-K, Item 2.02 · Filed · SEC filing

Hydrofarm Holdings Group Announces

First

Quarter

2026

Results

Shoemakersville, PA — May 15, 2026 — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its first quarter ended

March 31, 2026.

Comparison of First Quarter vs. Prior Year Period:

Financial statements

Income Statement

Three months ended March 31, — (In thousands, except share and per share amounts)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Net sales28,52440,534
Cost of goods sold26,68733,657
Gross profit1,8376,877
Operating expenses:Selling, general and administrative10,56817,863
Operating expenses:Loss from operations-8,731-10,986
Operating expenses:Interest expense-5,866-3,377
Operating expenses:Other (expense) income, net-12260
Operating expenses:Loss before tax-14,719-14,303
Operating expenses:Income tax benefit (expense)108-82
Operating expenses:Net loss-14,611-14,385
Net loss per share:Basic-3.07-3.12
Net loss per share:Diluted-3.07-3.12
Weighted-average shares of common stock outstanding:Basic4,763,7314,614,510
Weighted-average shares of common stock outstanding:Diluted4,763,7314,614,510

Income Statement

Three months ended March 31, — (Unaudited) (in thousands)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Reconciliation of Adjusted Gross Profit:Gross Profit (GAAP)1,8376,877
Reconciliation of Adjusted Gross Profit:Depreciation, depletion and amortization9911,313
Reconciliation of Adjusted Gross Profit:Restructuring expenses11,689342
Reconciliation of Adjusted Gross Profit:Adjusted Gross Profit (Non-GAAP)4,5178,532
As a percent of net sales:Gross Profit Margin (GAAP)6.4%17
As a percent of net sales:Adjusted Gross Profit Margin (Non-GAAP)15.8%21

Income Statement

Three months ended March 31, — (Unaudited) (in thousands)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Reconciliation of Adjusted SG&A:Selling, general and administrative (GAAP)10,56817,863
Reconciliation of Adjusted SG&A:Depreciation, depletion and amortization405,996
Reconciliation of Adjusted SG&A:Restructuring expenses180820
Reconciliation of Adjusted SG&A:Other241184
Reconciliation of Adjusted SG&A:Stock-based compensation3170475
Reconciliation of Adjusted SG&A:Debt transactions and strategic alternatives41,060208
Reconciliation of Adjusted SG&A:Adjusted SG&A (Non-GAAP)8,44910,980
As a percent of net sales:SG&A (GAAP)37.0%44.1
As a percent of net sales:Adjusted SG&A (Non-GAAP)29.6%27.1

Income Statement

Three months ended March 31, — Exhibit 99.1

Three months ended March 31, – 2026Three months ended March 31, – 2025
Reconciliation of Adjusted EBITDA:Net loss (GAAP)-14,611-14,385
Reconciliation of Adjusted EBITDA:Interest expense5,8663,377
Reconciliation of Adjusted EBITDA:Income tax (benefit) expense-10882
Reconciliation of Adjusted EBITDA:Depreciation, depletion and amortization1,0317,309
Reconciliation of Adjusted EBITDA:Restructuring expenses12,497362
Reconciliation of Adjusted EBITDA:Other241184
Reconciliation of Adjusted EBITDA:Stock-based compensation3170475
Reconciliation of Adjusted EBITDA:Debt transactions and strategic alternatives41,060208
Reconciliation of Adjusted EBITDA:Other expense (income), net5122-60
Reconciliation of Adjusted EBITDA:Adjusted EBITDA (Non-GAAP)-3,932-2,448
As a percent of net sales:Net loss (GAAP)-51.2%-35.5%
As a percent of net sales:Adjusted EBITDA (Non-GAAP)-13.8%-6.0%

Balance Sheet

March 31, 2026 — (In thousands, except share and per share amounts)

March 31, 2026December 31, 2025
Current assets:Cash and cash equivalents4,8116,309
Current assets:Restricted cash537
Current assets:Accounts receivable, net12,0828,186
Current assets:Inventories28,80633,324
Current assets:Prepaid expenses and other current assets2,8853,622
Current assets:Assets held for sale1,415
Current assets:Total current assets50,53651,441
Current assets:Property, plant and equipment, net27,64930,334
Current assets:Operating lease right-of-use assets35,55937,765
Current assets:Intangible assets, net2,8012,801
Current assets:Other assets1,2151,463
Current assets:Total assets117,760123,804
Current liabilities:Accounts payable14,5269,752
Current liabilities:Accrued expenses and other current liabilities12,1967,688
Current liabilities:Deferred revenue1,7552,742
Current liabilities:Current portion of operating lease liabilities7,5767,543
Current liabilities:Current portion of finance lease liabilities451455
Current liabilities:Current portion of long-term debt114,419111,853
Current liabilities:Total current liabilities150,923140,033
Current liabilities:Long-term operating lease liabilities30,64532,800
Current liabilities:Long-term finance lease liabilities7,2637,381
Current liabilities:Long-term debt4450
Current liabilities:Deferred tax liabilities2,1312,130
Current liabilities:Other long-term liabilities4,8894,706
Current liabilities:Total liabilities195,895187,100
Stockholders’ deficitAdditional paid-in capital791,380791,227
Stockholders’ deficitAccumulated other comprehensive loss-7,653-7,272
Stockholders’ deficitAccumulated deficit-861,862-847,251
Stockholders’ deficitTotal stockholders’ deficit-78,135-63,296
Stockholders’ deficitTotal liabilities and stockholders’ deficit117,760123,804

Cash Flow

Three months ended March 31, — Exhibit 99.1

Three months ended March 31, – 2026Three months ended March 31, – 2025
Reconciliation of Free Cash Flow:Net cash used in operating activities (GAAP):-759-11,763
Reconciliation of Free Cash Flow:Capital expenditures of Property, plant and equipment (GAAP)-19-244
Full release

(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the

“

Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the

“

Reconciliation of Non-GAAP Measures” accompanying this release.

William Toler Chief Executive Officer of Hydrofarm, said, "In the first quarter, we continued to execute on our strategic priorities. We have completed the consolidation of our U.S. manufacturing facilities into one location. During the quarter, we significantly reduced Adjusted SG&A expense by 23.1% compared to the prior year, representing our 15 th consecutive quarter of meaningful year-over-year expense reductions. Free Cash Flow in the first quarter was also a significant improvement over the prior year. We are focused on positioning the business to drive high quality revenue streams, improved profitability, and strengthen our financial position."

Exhibit 99.1

First

Quarter

2026

Financial Results

Net sales decreased 29.6% to $28.5 million compared to $40.5 million in the prior year period. This was due to a decline in volume/mix of products sold primarily related to industry oversupply.

Gross Profit decreased to $1.8 million, or 6.4% of net sales, compared to $6.9 million, or 17.0% of net sales, in the prior year period. Gross profit and gross profit margin were negatively impacted by $1.7 million of restructuring expenses in the first quarter. Adjusted Gross Profit

(1) decreased to $4.5 million, or 15.8% of net sales, compared to $8.5 million, or 21.0% of net sales, in the prior year period. The decreases in Gross Profit, Gross Profit Margin, Adjusted Gross Profit

(1) and Adjusted Gross Profit Margin

(1) were primarily due to lower net sales as well as lower production volumes and productivity at manufacturing facilities.

Selling, general and administrative (“SG&A”) expense improved to $10.6 million, compared to $17.9 million in the prior year period, and Adjusted SG&A

(1) expense improved to $8.4 million compared to $11.0 million in the prior year period. Lower amortization expense contributed to the reduction in SG&A. In addition, both SG&A and Adjusted SG&A

(1) expenses decreased primarily as a result of the Company's restructuring actions and cost saving initiatives, primarily attributable to a $1.2 million decrease in employee compensation costs.

Net loss was $14.6 million, or $(3.07) per diluted share, compared to net loss of $14.4 million, or $(3.12) per diluted share in the prior year period. Net loss declined primarily due to lower net sales, lower gross profit, and higher interest expense, partially offset by SG&A reductions.

Adjusted EBITDA

(1) decreased to $(3.9) million, compared to $(2.4) million in the prior year period. The reduction was related to lower net sales and lower Adjusted Gross Profit

(1), partially offset by Adjusted SG&A

(1) expense reductions.

Balance Sheet, Liquidity and Cash Flow

As of

March 31, 2026, the Company had $4.8 million in cash and $0.5 million in restricted cash. The Company ended the first quarter with $114.4 million in principal balance on its Term Loan outstanding, $7.7 million in finance leases, and $0.1 million in other debt outstanding.

Cash used in operating activities was $(0.8) million and the Company invested less than $0.1 million in capital expenditures, yielding Free Cash Flow

(1) of $(0.8) million during the three months ended

March 31, 2026.

Free Cash Flow

(1) improved by $11.2 million compared to the prior year.

On February 4, 2026, the Company elected to defer making the interest payment of approximately $2.8 million on the Term Loan. As a result of the Company’s failure to pay the interest within the grace period, an event of default occurred with respect to the Term Loan. As a result of the event of default, the Term Loan was reclassified to current portion of long-term debt from long-term debt. On April 8, 2026, the Company entered into a Forbearance Agreement with the Term Loan lenders requiring certain provisions and reporting obligations, including a $1 million minimum liquidity threshold and regular budget approvals. As of the date of this earnings release, the Forbearance Agreement is continuing. The Company and its Board of Directors are exploring strategic alternatives to strengthen the Company’s liquidity and capital structure, and are engaged in ongoing discussions with the Term Loan lenders.

Exhibit 99.1

Strategic Priorities

Hydrofarm remains committed to its strategic priorities: drive high-quality revenue streams, improve profit margins and strengthen financial position.

While maintaining our dedication to customer service, we are focused on reducing costs and improving productivity within the organization. Our initiatives include implementing operational changes, consolidating our facility footprint, reducing headcount, and focusing our sales efforts on our proprietary brand offerings.... (truncated)sted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the

“

Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the

“

Reconciliation of Non-GAAP Measures” accompanying this release.

About Hydrofarm Holdings Group, Inc.

Hydrofarm is a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative proprietary branded products. For over 40 years, Hydrofarm has helped growers make growing easier and more productive. The Company’s mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency and speed in their grow projects.

Exhibit 99.1

Cautionary Note Regarding Forward-Looking Statements

Statements contained in this press release, other than statements of historical fact, which address activities, events and developments that the Company expects or anticipates will or may occur in the future, including, but not limited to, information regarding the future economic performance and financial condition of the Company, the plans and objectives of the Company’s management, and the Company’s assumptions regarding such performance and plans are “forward-looking statements” within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. These forward-looking statements generally can be identified as statements that include phrases such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” or other similar words or phrases. Actual results could differ materially from the forward-looking information in this release due to a variety of factors, including, but not limited to:

The Company's ability to continue as a going concern; The Company's level of indebtedness; The market in which the Company operates has been substantially adversely impacted by conditions of the agricultural and cannabis industries, including oversupply and decreasing prices of the products the Company's end customers sell, which, in turn, has materially adversely impacted the Company's sales and other results of operations and which may continue to do so in the future; If industry conditions worsen or are sustained for a lengthy period, the Company could be forced to take additional impairment charges and/or inventory and accounts receivable reserves, which could be substantial, and, ultimately, the Company may face liquidity challenges; The Company’s current and future debt facilities may limit the operation of the Company’s business including restricting its ability to sell products directly to the cannabis industry; Although equity financing may be available, the Company's current stock prices are at depressed levels and any such financing would be dilutive; Interruptions in the Company's supply chain could adversely impact expected sales growth and operations; Increased prices and inflation could adversely impact the Company's performance and financial results; Global political and economic conditions including the imposition of potential tariffs could increase the costs of the Company's products and adversely impact the competitiveness of the Company's products and the Company's financial results; The Company may be unable to regain compliance and continue to meet the continued listing standards of Nasdaq; The Company's restructuring activities may increase our expenses and cash expenditures, and may not have the intended cost saving effects; The highly competitive nature of the Company’s markets could adversely affect its ability to maintain or grow revenues; Certain of the Company’s products may be purchased for use in new or emerging industries or segments, including the cannabis industry, and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative and enforcement approaches, and consumer perceptions which may adversely impact the market for the Company’s products; The market for the Company’s products has been impacted by conditions impacting its customers, including related crop prices, climate change, and other factors impacting growers; Compliance with government laws and regulations including environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase the Company’s costs of doing business or limit the Company’s ability to market all of its products; Damage to the Company’s reputation or the reputation of its products or products it markets on behalf of third parties could have an adverse effect on its business; If the Company is unable to effectively execute its e-commerce business, its reputation and operating results may be harmed; The Company’s operations may be impaired if its information technology systems fail to perform adequately or if it is the subject of a data breach or cyber-attack; The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to the Company’s business; Acquisitions, other strategic alliances and investments could result in operating and integration difficulties, dilution and other harmful consequences that may adversely impact the Company’s business and results of operations. Additional detailed information concerning a number of the important factors that could cause actual results to differ materially from the forward-looking information contained in this release is readily available in the Company’s annual, quarterly and other reports. The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments except as otherwise required by law.

Contacts:

Investor Contact ir@hydrofarm.com

Exhibit 99.1

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Hydrofarm Holdings Group earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.